Protalix BioTherapeutics
PLX
#8803
Rank
NZ$0.41 B
Marketcap
NZ$5.10
Share price
11.28%
Change (1 day)
35.15%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2026 (TTM): NZ$43.08 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$80.61 Million. In 2025 the company made an earning of -NZ$7.6 Million a decrease over its 2024 earnings that were of NZ$9.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$43.08 M-667.65%
2025 -NZ$7.6 Million-181.6%
2024 NZ$9.3 M-55.62%
2023 NZ$20.96 M-199.05%
2022 -NZ$21.17 Million-40.38%
2021 -NZ$35.5 Million-732.31%
2020 NZ$5.61 M-130.53%
2019 -NZ$18.39 Million189.85%
2018 -NZ$6.35 Million-95.29%
2017 -NZ$0.14 Billion308.12%
2016 -NZ$33.02 Million-32.37%
2015 -NZ$48.82 Million10.11%
2014 -NZ$44.34 Million-7.59%
2013 -NZ$47.98 Million
2011 -NZ$55.56 Million-19.39%
2010 -NZ$68.92 Million20.87%
2009 -NZ$57.02 Million32.26%
2008 -NZ$43.11 Million-5.46%
2007 -NZ$45.6 Million
2004 -NZ$0.3 Million12.35%
2003 -NZ$0.27 Million-11.1%
2002 -NZ$0.3 Million-57.03%
2001 -NZ$0.69 Million1.03%
2000 -NZ$0.69 Million-53.22%
1999 -NZ$1.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.42 B 28,094.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.53 B 3,391.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.34 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.18 B 4,852.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel